Record Numbers of Cancer Drugs Approved- But Leading Experts Say Vital Clinical Trials Could Drop Off Hugely Due To COVID-19

Published May 29, 2020

Record Numbers of Cancer Drugs Approved- But Leading Experts Say Vital Clinical Trials Could Drop Off Hugely Due To COVID-19

There has been a wave of new FDA approved drugs targeted towards cancer patients so far this year, but as the coronavirus pandemic halts current research, future approvals may be in jeopardy

NOW
PLAYING
New Hope For Esophageal Cancer Patients -- Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer
NOW
PLAYING
The Urgent National Problem-- Too Many Cancer Patients Not Seeking Treatment-- The Fear of Leaving Home
NOW
PLAYING
Using PARP Inhibitors Earlier in Ovarian Cancer Treatment
NOW
PLAYING
Ovarian Cancer Treatment during the COVID-19 Pandemic
NOW
PLAYING
New Hope For Lung Cancer Patients -- FDA Approves Drug Combination Opdivo And Yervoy For First Course Treatment
NOW
PLAYING
New Research Shows People With Cancer More Likely to Die of COVID-19 - Breaking Down the Data
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.